Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Over-representation of a germline variant in the gene encoding RET co-receptor GFRα-1 but not GFRα-2 or GFRα-3 in cases with sporadic medullary thyroid carcinoma

Oncogene volume 20, pages 2161–2170 (2001)Cite this article

Abstract

In contrast to the hereditary form of medullary thyroid carcinoma (MTC), little is known about the etiology of sporadic MTC. Somatic gain-of-function mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, are found in an average of 40% of sporadic MTC. We analysed 31 sporadic MTC for somatic and germline variants in GFRA1, GFRA2 and GFRA3 which encode the co-receptors of RET. Although there were no somatic mutations in any of the three genes, a sequence variant (−193C>G) in the 5′-UTR of GFRA1 was found in 15% of cases. Three patients were heterozygous (het); another three patients homozygous (hom) for the G variant. The G allele was not observed in 31 race-matched normal controls. Hence, the relative frequency of this variant in sporadic MTC cases and controls differed significantly (P<0.05). Since this variant lies in the 5′ UTR, likely at the transcriptional start site, we analysed for differential expression of GFRα-1 at the transcript and protein levels. At the mRNA level, GFRA1 was over-expressed in tumors harboring the rare variant (P=0.06). The presence of the G polymorphic allele seemed to be associated with increased expression by immunostaining for GFRα-1. Interestingly, cytoplasmic staining was stronger in intensity for het patients and nuclear staining predominant in hom cases. In conclusion, mutation analysis of GFRA1, GFRA2 and GFRA3 revealed over-representation of a rare variant in GFRA1 (−193C>G) in the germline of sporadic MTC cases. Our data suggest that the mechanism is related to over-expression of GFRα-1 and differential subcellular compartmentalization but the precise mechanism as to how it acts as a low penetrance susceptibility allele for the development of sporadic MTC remains to be elucidated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Airaksinen MS, Titievsky A, Saarma M . 1999 Mol. Cell. Neurosci. 13: 313–325

  • Angrist M, Jing S, Bolk S, Bentley K, Nallasamy S, Halushka M, Fox GM, Chakravarti A . 1998 Genomics 48: 354–362

  • Baloh RH, Enomoto H, Johnson Jr EM, Milbrandt J . 2000 Curr. Opin. Neurobiol 10: 103–110

  • Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, Leitner ML, Araki T, Johnson Jr EM, Milbrandt J . 1998 Neuron 21: 1291–1302

  • Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells Jr SA, Goodfellow PJ, Donis-Keller H . 1994 Proc. Natl. Acad. Sci. USA 91: 1579–1583

  • Ceccherini I, Griseri P, Sancandi M, Patrone G, Bocciardi R, Hofstra R, Ravazzolo R, Romeo G, Devoto M . 1999 Am. J. Hum. Genet. 65: A266

  • Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA . 1993 Hum. Mol. Genet 2: 851–856

  • Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V . 1996 Nature 381: 789–793

  • Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BA, Mulligan LM . 1996a JAMA 276: 1575–1579

  • Eng C, Mulligan LM . 1997 Hum. Mutat. 9: 97–109

  • Eng C, Mulligan LM, Healey CS, Houghton C, Grilling A, Raue F, Thomas GA, Ponder BA . 1996b Cancer Res. 56: 2167–2170

  • Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, Ponder BAJ . 1994 Hum. Mol. Genet. 3: 237–241

  • Enokido Y, de Sauvage F, Hongo JA, Ninkina N, Rosenthal A, Buchman VL, Davies AM . 1998 Curr. Biol. 8: 1019–1022

  • Gimm O, Attie-Bitach T, Lees JA, Vekemans M, Eng C . 2000 Hum. Mol. Genet. 9: 1633–1639

  • Gimm O, Gossling A, Marsh DJ, Dahia PL, Mulligan LM, von Deimling A, Eng C . 1999a Br. J. Cancer 80: 383–386

  • Gimm O, Greco A, Hoang-Vu C, Dralle H, Pierotti MA, Eng C . 1999b J. Clin. Endocrinol. Metab. 84: 2784–2787

  • Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PL, Mulligan LM, Zajac JD, Robinson BG, Eng C . 1997 J. Clin. Endocrinol. Metab. 82: 3902–3904

  • Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-Vu C, Raue F, Hinze R, Dralle H, Eng C . 1999c Oncogene 18: 1369–1373

  • Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G, Lips CJM, Buys CHCM . 1994 Nature 367: 375–376

  • Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM . 1996 Cell 85: 1113–1124

  • Jing S, Yu Y, Fang M, Hu Z, Holst PL, Boone T, Delaney J, Schultz H, Zhou R, Fox GM . 1997 J. Biol. Chem. 272: 33111–33117

  • Jordanova A, Kalaydjieva L, Savov A, Claustres M, Schwarz M, Estivill X, Angelicheva D, Haworth A, Casals T, Kremensky I . 1997 Hum. Mutat. 10: 65–70

  • Klein RD, Sherman D, Ho WH, Stone D, Bennett GL, Moffat B, Vandlen R, Simmons L, Gu Q, Hongo JA, Devaux B, Poulsen K, Armanini M, Nozaki C, Asai N, Goddard A, Phillips H, Henderson CE, Takahashi M, Rosenthal A . 1997 Nature 387: 717–721

  • Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson Jr EM, Milbrandt J . 1996 Nature 384: 467–470

  • Masure S, Geerts H, Cik M, Hoefnagel E, Van Den Kieboom G, Tuytelaars A, Harris S, Lesage AS, Leysen JE, Van Der Helm L, Verhasselt P, Yon J, Gordon RD . 1999 Eur. J. Biochem 266: 892–902

  • Milbrandt J, de Sauvage FJ, Fahrner TJ, Baloh RH, Leitner ML, Tansey MG, Lampe PA, Heuckeroth RO, Kotzbauer PT, Simburger KS, Golden JP, Davies JA, Vejsada R, Kato AC, Hynes M, Sherman D, Nishimura M, Wang LC, Vandlen R, Moffat B, Klein RD, Poulsen K, Gray C, Garces A, Johnson Jr EM . 1998 Neuron 20: 245–253

  • Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BA . 1993 Nature 363: 458–460

  • Myers SM, Salomon R, Goessling A, Pelet A, Eng C, von Deimling A, Lyonnet S, Mulligan LM . 1999 J. Med. Genet. 36: 217–220

  • Naveilhan P, Baudet C, Mikaels A, Shen L, Westphal H, Ernfors P . 1998 Proc. Natl. Acad. Sci. USA 95: 1295–1300

  • Onochie CI, Korngut LM, Vanhorne JB, Myers SM, Michaud D, Mulligan LM . 2000 J. Med. Genet. in press

  • Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M . 1996 Nature 382: 70–73

  • Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, Whitty A, Pepinsky RB, Cate RL . 1997 Proc. Natl. Acad. Sci. USA 94: 6238–6243

  • Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V . 1994 Nature 367: 380–383

  • Takahashi M, Cooper GM . 1987 Mol. Cell. Biol. 7: 1378–1385

  • Thompson J, Doxakis E, Pinon LG, Strachan P, Buj-Bello A, Wyatt S, Buchman VL, Davies AM . 1998 Mol. Cell. Neurosci. 11: 117–126

  • Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sariola H, Saarma M, Ibánez CF . 1996 Nature 381: 785–788

  • Trupp M, Raynoschek C, Belluardo N, Ibanez CF . 1998 Mol. Cell. Neurosci 11: 47–63

Download references

Acknowledgements

O Gimm thanks Dr Stephan M Tanner for helpful discussions. The authors acknowledge Kathrin Hammje, Marion Sitte and Irene Schwarz for technical assistance and Terry Bradley for graphics advice and assistance. This study was partially funded by 1R01HD39058-01 from the National Institutes of Health (to C Eng) and P30CA16058 from the National Cancer Institute (to Ohio State University Comprehensive Cancer Center).

Author information

Authors and Affiliations

  1. Clinical Cancer Genetics and Human Cancer Genetics Programs, Comprehensive Cancer Centre, and Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, 43210, Ohio, OH, USA

    Oliver Gimm, Heather Dziema, Jessica Brown & Charis Eng

  2. Department of General Surgery, Martin-Luther-University of Halle-Wittenberg, Halle/Saale, Germany

    Cuong Hoang-Vu & Henning Dralle

  3. Institute of Pathology, Martin-Luther-University of Halle-Wittenberg, Halle/Saale, Germany

    Raoul Hinze

  4. Department of Pathology, Queen's University, Kingston, ON K7L 3NR, Ontario, Canada

    Lois M Mulligan

  5. Department of Paediatrics, Queen's University, Kingston, ON K7L 3NR, Ontario, Canada

    Lois M Mulligan

  6. Cancer Research Campaign Human Cancer Genetics Research Group, University of Cambridge, Cambridge, CB2 2QQ, UK

    Charis Eng

Authors
  1. Oliver Gimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heather Dziema
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cuong Hoang-Vu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raoul Hinze
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Henning Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lois M Mulligan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Charis Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gimm, O., Dziema, H., Brown, J. et al. Over-representation of a germline variant in the gene encoding RET co-receptor GFRα-1 but not GFRα-2 or GFRα-3 in cases with sporadic medullary thyroid carcinoma. Oncogene 20, 2161–2170 (2001). https://doi.org/10.1038/sj.onc.1204289

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204289

Keywords

Search

Advanced search

Quick links